| # | Drug | Count |
|---|---|---|
| 0 | CETUXIMAB | 2 |
| 1 | CISPLATIN | 2 |
| 2 | DOCETAXEL | 2 |
| 3 | DOCETAXEL ANHYDROUS | 2 |
| 4 | FLUOROURACIL | 2 |
| 5 | FLUOROURACIL CREAM, 0.5% | 2 |
| 6 | LIRAGLUTIDE | 2 |
| 7 | PACLITAXEL | 2 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 9 | APALUTAMIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALOVAROTENE | 1 | 0.0141 |
| 1 | ZANUBRUTINIB | 1 | 0.0002 |
| 2 | APALUTAMIDE | 1 | 0.0001 |
| 3 | TOFACITINIB CITRATE | 1 | 0.0001 |
| 4 | ROMOSOZUMAB-AQQG | 1 | 0.0001 |
| 5 | CETUXIMAB | 2 | 0.0001 |
| 6 | LIRAGLUTIDE | 2 | 0.0000 |
| 7 | RABEPRAZOLE SODIUM | 1 | 0.0000 |
| 8 | VALPROIC ACID | 1 | 0.0000 |
| 9 | DOCETAXEL | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 1 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Mood Stabilizer [EPC] | 2 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |
| 7 | GLP-1 Receptor Agonist [EPC] | 2 | 0.0000 |
| 8 | Retinoid [EPC] | 1 | 0.0000 |
| 9 | Opioid Agonist [EPC] | 1 | 0.0000 |